HK Johansen, HP Hougen, SJ Cryz Jr, J Rygaard and N Hoiby
Department of Clinical Microbiology, University Institute of Forensic Medicine, Bartholin Institute, Copenhagen, Denmark.

In a rat model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis (CF) we studied whether the inflammatory response could be altered by vaccination. Rats were immunized with either a depolymerized alginate toxin A conjugate (D-ALG toxin A), purified alginate, an O-polysaccharide toxin A conjugate, or sterile saline. After challenge none of the rats immunized with D-ALG toxin A died, in contrast to the other two vaccine groups combined (p = 0.03). A significant reduction in the severity of the macroscopic lung inflammation was seen in rats immunized with D-ALG toxin A, compared with the other three groups (p = 0.009). The histopathologic response in the control rats was dominated by numerous polymorphonuclear leukocytes (PMN) surrounding the alginate beads. In contrast, the histopathologic response in rats immunized with D-ALG toxin A changed within the first week after challenge from predominantly PMNs (TH2- like) to a chronic-type inflammation dominated by mononuclear leukocytes (TH1-like). In accordance, the antibody titers induced by the D-ALG toxin A vaccine were not different from those of the control rats after challenge. This study identifies a possible new way of modifying the inflammation and thereby preventing the PMN-mediated lung tissue damage during chronic P. aeruginosa lung infection in CF.

This article has been cited by other articles:

				N. Hoffmann, B. Lee, M. Hentzer, T. B. Rasmussen, Z. Song, H. K. Johansen, M. Givskov, and N. Hoiby Azithromycin Blocks Quorum Sensing and Alginate Polymer Formation and Increases the Sensitivity to Serum and Stationary-Growth-Phase Killing of Pseudomonas aeruginosa and Attenuates Chronic P. aeruginosa Lung Infection in Cftr / Mice Antimicrob. Agents Chemother., October 1, 2007; 51(10): 3677 - 3687. [Abstract] [Full Text] [PDF]

				N. Kashef, Q. Behzadian-Nejad, S. Najar-Peerayeh, K. Mousavi-Hosseini, M. Moazzeni, and G. E. Djavid Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate. J. Med. Microbiol., October 1, 2006; 55(Pt 10): 1441 - 1446. [Abstract] [Full Text] [PDF]

				N. Hoffmann, T. B. Rasmussen, P. Jensen, C. Stub, M. Hentzer, S. Molin, O. Ciofu, M. Givskov, H. K. Johansen, and N. Hoiby Novel Mouse Model of Chronic Pseudomonas aeruginosa Lung Infection Mimicking Cystic Fibrosis Infect. Immun., April 1, 2005; 73(4): 2504 - 2514. [Abstract] [Full Text] [PDF]

				H. Arnold, D. Bumann, M. Felies, B. Gewecke, M. Sorensen, J. E. Gessner, J. Freihorst, B. U. von Specht, and U. Baumann Enhanced Immunogenicity in the Murine Airway Mucosa with an Attenuated Salmonella Live Vaccine Expressing OprF-OprI from Pseudomonas aeruginosa Infect. Immun., November 1, 2004; 72(11): 6546 - 6553. [Abstract] [Full Text] [PDF]

				H. Wu, Z. Song, M. Hentzer, J. B. Andersen, S. Molin, M. Givskov, and N. Hoiby Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice J. Antimicrob. Chemother., June 1, 2004; 53(6): 1054 - 1061. [Abstract] [Full Text] [PDF]

				L. M. Schwiebert Cystic fibrosis, gene therapy, and lung inflammation: for better or worse? Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L715 - L716. [Full Text] [PDF]

				A. M. van Heeckeren, M. Schluchter, L. Xue, J. Alvarez, S. Freedman, J. St. George, and P. B. Davis Nutritional Effects on Host Response to Lung Infections with Mucoid Pseudomonas aeruginosa in Mice Infect. Immun., March 1, 2004; 72(3): 1479 - 1486. [Abstract] [Full Text] [PDF]

				C. Theilacker, F. T. Coleman, S. Mueschenborn, N. Llosa, M. Grout, and G. B. Pier Construction and Characterization of a Pseudomonas aeruginosa Mucoid Exopolysaccharide-Alginate Conjugate Vaccine Infect. Immun., July 1, 2003; 71(7): 3875 - 3884. [Abstract] [Full Text] [PDF]